A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301558 | PMC |
| http://dx.doi.org/10.1002/ccr3.4417 | DOI Listing |
Publication Analysis
Top Keywords
arsenic trioxide
12
acute promyelocytic
8
promyelocytic leukemia
8
successful treatment
4
treatment acute
4
leukemia patient
4
patient hemodialysis
4
hemodialysis arsenic
4
trioxide man
4
man chronic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!